logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Javier Gállego

medical oncology department
H指数:33
被引数:5,424

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical documentation of social determinants in advanced colorectal cancer: preliminary results of GEO-CRC study

晚期结直肠癌的社会决定因素临床记录：GEO-CRC研究的初步结果

Clinical & Translational Oncology
IF2.5
2026-09-170
OAAI
Francisco José Pelegrín-Mateo; Álvaro Muñoz Abad; Beatriz Grau Mirete; Mariano Martínez Marín; Cristina Bernabé Martínez; Elena Navarro Vicente; María Orengo López; Marta Hernández Sáez; Jose María Barón Saura; Elena Asensio Martínez; Javier Gallego Plazas
Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHEIA-SEOM cohort

转移性胰腺癌总生存期的预后模型：一种基于炎症的工具在PANTHEIA-SEOM队列中的验证

Clinical & Translational Oncology
IF2.5
2026-09-030
OAAI
Vilma Pacheco-Barcia; Axel Mariño-Mendez; María Ángeles Vicente Conesa; María de Toro Carmena; Paula Cerdà Serdà; Carmen Guillen-Ponce; Mónica Benavente Lucas; Raquel Hernández San Gil; Ángela Lamarca; Javier Gallego; Maria Luisa Soriano Tabares de Nava; Jorge Hernando; Elena Brozos-Vazquez; Ana López-Alfonso; Jorge Adeva; Ismael Ghanem; Sandra Soriano; Javier Soto-Alsar; Andrés Muñoz; Paula Jimenez-Fonseca; Alberto Carmona-Bayonas
Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis

解析补体系统基因在胰腺癌易感性和预后中的作用

Nature Communications
IF15.7
2025-11-280
OAAI
Alberto Langtry; Raul Rabadan; Lola Alonso; Ioan Filip; Sergio Sabroso-Lasa; Ane Moreno-Oya; Rita Lawlor; Alfredo Carrato; Rafael Alvarez-Gallego; Mar Iglesias; Xavier Molero; Matthias J. Löhr; Christoph W. Michalski; José Perea; Michael O’Rorke; Victor M. Barberà; Adonina Tardón; Antoni Farré; Luís Muñoz-Bellvís; Tatjana Crnogorac-Jurcevic; Enrique Domínguez-Muñoz; Thomas M. Gress; William Greenhalf; Linda Sharp; Joaquim Balsells; Eithne Costello; Jörg Kleeff; Bo Kong; Josefina Mora; Damian O’Driscoll; Aldo Scarpa; Weimin Ye; Francisco X. Real; Evangelina López de Maturana; Núria Malats; Alberto Langtry; Lola Alonso; Sergio Sabroso-Lasa; Ane Moreno-Oya; Paulina Gómez-Rubio; Esther Molina-Montes; Mirari Márquez; Roger Milne; Ana Alfaro; Tania Lobato; Lidia Estudillo; Francisco X. Real; Núria Malats; Aldo Scarpa; Rita Lawlor; Stefania Beghelli; Rafael Alvarez-Gallego; Antonio Cubillo; Manuel Hidalgo; Paloma Peinado; Isabel Salas; Jesús Rodríguez Pascual; Alfredo Carrato; Julie Earl; Alejandra Caminoa; Carmen Guillén-Ponce; Mercedes Rodríguez-Garrote; Federico Longo-Muñoz; Reyes Ferreiro; Vanessa Pachón; M. Ángeles Vaz; María Muñoz; Mar Iglesias; Lucas Ilzarbe; Cristina Álvarez-Urturi; Xavier Bessa; Felipe Bory; Lucía Márquez; Ignasi Poves; Fernando Burdío; Luis Grande; Javier Gimeno; Xavier Molero; Luisa Guarner; Joaquín Balcells; Mayte Salcedo; Xavier Merino; Christoph W. Michalski; Irene Esposito; Jörg Kleeff; Bo Kong; Carmen Mota; Matthias J. Löhr; Jiaqui Huang; Caroline Verbeke; Weimin Ye; Jingru Yu; Carmelo Loinaz; José Perea; José Luis Rodríguez-Peralto; Ana Teijo; Pablo Peláez; Antoni Farré; Josefina Mora; Marta Martín; Vicenç Artigas; Carlos Guarner; Francesc J. Sancho; Mar Concepción; Teresa Ramón y Cajal; Justyna Szafranska; Michael O’Rorke; Liam Murray; Marie Cantwell; Victor M. Barberà; Javier Gallego; Adonina Tardón; Luis Barneo; MM Rodriguez-Suarez; Enrique Domínguez-Muñoz; Yolanda Pazos; Antonio Lozano; Maria Luaces; Francisco Blanco-Antona; J. M. Sayagués Manzano; M. L. Gutiérrez Troncoso; A. Orfao de Matos; Luís Muñoz-Bellvís; Thomas M. Gress; Malte Buchholz; Albrecht Neesse; William Greenhalf; Eithne Costello; Tatjana Crnogorac-Jurcevic; Hemant M. Kocher; Satyajit Bhattacharya; Ajit T. Abraham; Darren Ennis; Thomas Dowe; Tomasz Radon; Damian O’Driscoll; Linda Sharp
Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis

围术期FLOT疗法是否能提高可切除食管腺癌的治愈率？——混合治愈模型分析

British Journal of Cancer
IF6.8
2025-11-260
OAAI
Lucía Mateos; Paula Jiménez-Fonseca; Javier Gallego; Arturo Lecumberri; Ana Custodio; Eva Martínez de Castro; Raquel Hernández San Gil; Ana Fernández Montes; María Luisa Limón; Rosario Vidal-Tocino; Juana María Cano; Javier López Robles; Mireia Gil; Daniel Acosta Eyzaguirre; Gema Marín Zafra; Antonio José Mérida-García; Alejandro Francisco Fernández; Paula Ribera Fernández; Cinta Hierro; María Carmen Riesco; Montse García Araque; Maribel Ruiz Martín; Paola Pimentel; Laura Visa; Paula Cerdá; Mónica Granja; Ana Belén Rupérez Blanco; Lourdes Gutiérrez; Alberto Carmona-Bayonas
Correction: Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study

更正：高血压作为贝伐珠单抗含药一线疗法在转移性乳腺癌和结直肠癌中的预测因素（BRECOL [GEICAM/2011-04] 研究）。

Clinical and Translational Oncology
IF2.5
2025-11-250
OAAI
Álvaro Rodríguez-Lescure; Javier Gallego; Pilar Garcia-Alfonso; Bartomeu Massuti; Raúl Márquez; Lourdes Calvo; Pedro Sánchez-Rovira; Antonio Antón; José Ignacio Chacón; Eva Ciruelos; Jose Juan Ponce; Ana Santaballa; Manuel Valladares-Ayerbes; María Rosario Dueñas; Vicente Alonso; Jorge Aparicio; Sara Encinas; Luis Robles; María José Escudero; Rosalía Caballero; Susana Bezares; María Victoria García-Ortiz; Teresa Morales-Ruiz; Juan de la Haba-Rodriguez
Real-world management and outcomes of patients with hepatocellular carcinoma treated with systemic therapy in Spain: a patient cohort from the RETUD gastrointestinal registry

西班牙接受全身治疗肝细胞癌患者的实际管理及预后：来自RETUD消化道登记研究的患者队列

clinical translational oncology
IF0
2025-08-090
OA
Carlos López-López; Eva Martínez de Castro; Ana Fernández Montes; Encarnación Jiménez Orozco; Sandra López Peraita; Ruth Vera; Paula Cerdá; Mariona Calvo; Beatriz García Paredes; Miriam Lobo de Mena; Adelaida La Casta; Javier Gallego; Jorge Adeva; Juana Mª Cano Cano; Ana Ruiz-Casado; Rosario Vidal-Tocino; Teresa García-García; Roberto Pazo-Cid; Mercedes Rodríguez Garrote; Javier Sastre
Positive ad hoc results from neoadjuvant Foxy-5 treatment of colon cancer patients in the ongoing phase II NeoFox study
ANNALS OF ONCOLOGY
IF65.4
2024-06-010
PRE
Salazar Soler, R.; Santos Vivas, C.; Macias, I.; Yubero Esteban, A.; Bassam, A.; Gallego Plazas, J.; Al-Farhat, Y.; Cervantes, A.; Garcia Alfonso, P.; Paez, D.; Ruiz-Casado, A.; Lopez, C.; Arkosy, P. F.; Furka, A.; Rodriguez-Salas, N.; Ramos Pascual, F. J.; Cubillo Gracian, A.; Hitre, E.; Ferreiro Monteagudo, R.; Salud Salvia, M. A.
Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry
GASTRIC CANCER
IF5.1
2023-11-151
PRE
Perez-Wert, Pablo; Custodio, Ana; Jimenez-Fonseca, Paula; Carmona-Bayonas, Alberto; Lecumberri, Arturo; Cacho Lavin, Diego; Losantos Garcia, Itsaso; Fernandez Montes, Ana; Cano, Juana Maria; Limon, Maria Luisa; Hernandez San Gil, Raquel; Diez, Marc; Vidal Tocino, Rosario; Macias Declara, Ismael; Visa, Laura; Pimentel Caceres, Paola; Gil Raga, Mireia; Martinez Moreno, Elia; Sauri, Tamara; Martin Richard, Marta; Granja, Monica; Cerda, Paula; Gomez Gonzalez, Lucia; Merida-Garcia, Antonio; Ruiz Martin, Maribel; Gallego, Javier
Updated efficacy and safety results from phase III GLOW study evaluating zolbetuximab plus CAPOX as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2L, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma
ANNALS OF ONCOLOGY
IF65.4
2023-11-012
PRE
Lordick, F.; Shah, M. A.; Shitara, K.; Ajani, J. A.; Bang, Y-J.; Enzinger, P. C.; Ilson, D. H.; van Cutsem, E.; Gallego Plazas, J.; Huang, J.; Shen, L.; Oh, S. C.; Sunpaweravong, P.; Soo, H. H. F.; Turk, H. M.; Park, J. W.; Moran, D.; Bhattacharya, P.; Cao, Y. J.; Xu, R-H.
First-line chemotherapy with or without targeted therapies in metastatic colorectal cancer: The GEMCAD 14-01 prospective cohort
ANNALS OF ONCOLOGY
IF65.4
2023-10-010
PRE
Oliveres, H.; Alonso-Orduna, V.; Feliu, J.; Fernandez Montes, A.; Martin-Richard, M.; Galvez Munoz, E.; Ruiz-Casado, A.; Yubero Esteban, A.; Aparicio, J.; Alcaide-Garcia, J.; Gallego Plazas, J.; Carmona-Bayonas, A.; Fernandez Martos, C.; Gallego, M. R.; Manzano Alemany, H.; Leno, R.; Esposito, F. M.; Sapena, V.; Maurel, J.
The DUREC trial: Durvalumab plus total neoadjuvant therapy in locally advanced rectal cancer - a multicenter, single-arm, phase II study (GEMCAD-1703)
ANNALS OF ONCOLOGY
IF65.4
2023-10-010
PRE
Capdevila Castillon, J.; Alonso, V.; Macias Declara, I.; Melian, M.; Gallego Plazas, J.; Vera, R.; Riesco Martinez, M. C.; Maurel, J.; Grana Suarez, B.; Hernando, J.; Garcia Alvarez, A.; Navalpotro, B.; Soler Gonzalez, G.; Polo, E.; Garcia Fadrique, A.; Espin, E.; Fernandez Martos, C.; Villacampa Javierre, G.; Losa, F.
Olaparib and durvalumab (MEDI4736) phase II study in patients with metastatic pancreatic cancer and DNA damage repair genes alterations
ANNALS OF ONCOLOGY
IF65.4
2023-10-010
PRE
Macarulla, T.; Castet, F.; Lobo de Mena, M.; Garcia-Carbonero, R.; Martinez de Castro, E.; Munoz Martin, A. J.; Pazo Cid, R. A.; Grana Suarez, B.; Gallego Plazas, J.; Alvarez, R.; Ales Diaz, I. C.; Gallego Jimenez, I.; Laquente, B.; Rodriguez, M.; Garcia Paredes, B.; Cano Osuna, M. T.; Ruiz de Mena, I.; Fabregat-Franco, C.; Espinosa Olarte, P.; Aranda Aguilar, E.
Treatment patterns and efficacy in patients (pt) with pancreatic cancer (PC) from the Spanish RETUD registry
ANNALS OF ONCOLOGY
IF65.4
2023-10-010
PRE
Macarulla, T.; Munoz Martin, A. J.; Martinez de Castro, E.; Castillo Trujillo, A. O.; Cano Osuna, M. T.; Fabregat, C.; Vidal Tocino, R.; Gallego Plazas, J.; Ghanem, I.; Ales Diaz, I. C.; Vera, R.; Lobo de Mena, M.; Adeva Alfonso, J.; Melian, M.; Gallego Jimenez, I.; Laquente, B.; Fernandez Montes, A.; Peinado Martin, P.; Carrato Mena, A.; Aranda Aguilar, E.
Cabozantinib plus atezolizumab in advanced and progressive neoplasms of the endocrine system: A multi-cohort basket phase II trial (CABATEN/GETNE-T1914)
ANNALS OF ONCOLOGY
IF65.4
2023-10-016
PRE
Capdevila Castillon, J.; Molina-Cerrillo, J.; Benavent Vinuales, M.; Garcia-Carbonero, R.; Teule, A.; Custodio, A.; Jimenez-Fonseca, P.; Lopez, C.; Hierro, C.; Carmona-Bayonas, A.; Martinez-Trufero, J.; Llanos, M.; Sevilla, I.; Hernando, J.; Alonso-Gordoa, T.; Gallego Jimenez, I.; Gallego, J.; Anton Pascual, B.; Grande, E.
Updated efficacy and safety results from phase III GLOW study evaluating zolbetuximab plus CAPOX as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2L, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma
ANNALS OF ONCOLOGY
IF65.4
2023-10-011
PRE
Lordick, F.; Shah, M. A.; Shitara, K.; Ajani, J. A.; Bang, Y-J.; Enzinger, P. C.; Ilson, D. H.; Van Cutsem, E.; Plazas, J. Gallego; Huang, J.; Shen, L.; Oh, S. C.; Sunpaweravong, P.; Soo, H. H. F.; Turk, H. M.; Park, J. W.; Moran, D.; Bhattacharya, P.; Cao, Y. J.; Xu, R-H.
Biliary tract cancer (BTC) characterization on a cohort of patients (pt) from the Spanish RETUD Registry
ANNALS OF ONCOLOGY
IF65.4
2023-10-010
PRE
Lacasta, A.; Macarulla, T.; Castillo Trujillo, A. O.; Herrera Juarez, M. M.; Munoz Martin, A. J.; Vidal Tocino, R.; Fabregat, C.; Rodriguez, R. M.; Lobo de Mena, M.; Peinado, P.; Granja Ortega, M.; Montes, A. Fernandez; Suarez, B. Grana; Martinez de Castro, E.; Gallego Plazas, J.; Vera, R.; Diaz, I. C. Ales; Ghanem, I.; Jimenez, I. Gallego; Aguilar, E. Aranda
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial

Zolbetuximab联合CAPOX治疗CLDN18.2阳性胃或胃食管交界处腺癌: 随机，3期GLOW试验

NATURE MEDICINE
IF50
2023-07-31158
OAAI
Shah, Manish A.; Shitara, Kohei; Ajani, Jaffer A.; Bang, Yung-Jue; Enzinger, Peter; Ilson, David; Lordick, Florian; Van Cutsem, Eric; Plazas, Javier Gallego; Huang, Jing; Shen, Lin; Oh, Sang Cheul; Sunpaweravong, Patrapim; Soo Hoo, Hwoei Fen; Turk, Haci Mehmet; Oh, Mok; Park, Jung Wook; Moran, Diarmuid; Bhattacharya, Pranob; Arozullah, Ahsan; Xu, Rui-Hua
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
2023-07-056
PRE
Pesantez, David; ten Hoorn, Sanne; Machado, Isidro; Garcia-Albeniz, Xabier; Rodriguez-Salas, Nuria; Heredia-Soto, Victoria; Vinal, David; Pericay, Carles; Garcia-Carbonero, Rocio; Losa, Ferran; Alonso, Vicente; Vera, Ruth; Feliu Batlle, Jaime; Gallego, Javier; Salud, Antonieta; Nogue, Miquel; Layos, Laura; Montagut, Clara; Capdevila, Jaume; Vermeulen, Louis; Maurel, Joan; Fernandez-Martos, Carlos
Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNu-1 and Phase II VISNu-2 Randomized Trials
CLINICAL COLORECTAL CANCER
IF3.2
2023-06-012
PRE
Jimenez-Fonseca, P.; Sastre, J.; Garcia-Alfonso, P.; Gomez-Espana, M. A.; Salud, A.; Gil, S.; Rivera, F.; Reina, J. J.; Quintero, G.; Valladares-Ayerbes, M.; Safont, M. J.; La Casta, A.; Robles-Diaz, L.; Garcia-Paredes, B.; Lopez, R. Lopez; Guillot, M.; Gallego, J.; Alonso-Orduna, V.; Diaz-Rubio, E.; Aranda, E.
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy

Agamenon-seom模型预测接受基于曲妥珠单抗的一线治疗的晚期HER2-positive食管胃腺癌患者的生存

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2023-03-041
OAAI
Jimenez-Fonseca, Paula; Foy, Victoria; Raby, Sophie; Carmona-Bayonas, Alberto; Macia-Rivas, Lola; Arrazubi, Virginia; Lavin, Diego Cacho; Gil, Raquel Hernandez San; Custodio, Ana; Cano, Juana Maria; Montes, Ana Fernandez; Mirallas, Oriol; Declara, Ismael Macias; Tocino, Rosario Vidal; Visa, Laura; Limon, Maria Luisa; Pimentel, Paola; Lago, Nieves Martinez; Sauri, Tamara; Richard, Marta Martin; Mangas, Monserrat; Gil Raga, Mireia; Calvo, Aitana; Reguera, Pablo; Granja, Monica; Carnicero, Alfonso Martin; Perez, Carolina Hernandez; Cerda, Paula; Gonzalez, Lucia Gomez; Navalon, Francisco Garcia; Barcia, Vilma Pacheco; Abad, David; Martin, Maribel Ruiz; Weaver, Jamie; Mansoor, Wasat; Gallego, Javier

研究方向

暂未获取到该数据
A
Alberto Carmona‐Bayonas
H 指数:35论文数:299被引数:3,640
P
Paula Jiménez‐Fonseca
H 指数:41论文数:385被引数:5,504
E
Enrique Aranda
H 指数:49论文数:513被引数:1.5万
A
Ana Fernández Montés
H 指数:25论文数:281被引数:3,397
L
Laura Visa
H 指数:24论文数:102被引数:2,271
E
Eva Martínez de Castro
H 指数:18论文数:139被引数:1,122
M
María Luisa Limón
H 指数:20论文数:57被引数:1,408
C
Carles Pericay
H 指数:34论文数:225被引数:4,524
C
Carlos López
H 指数:46论文数:313被引数:1.1万
R
R. Vidal Tocino
H 指数:8论文数:76被引数:214